Specific triggers for medical consultation include achieving less than 5% body weight reduction after reaching the maintenance dose (for Wegovy, after 12 weeks at 2.4 mg as per FDA labeling), prolonged weight loss plateau despite adherence, or intolerable side effects preventing dose escalation to therapeutic levels
Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review
Global prevalence of persistent neuromuscular symptoms and the possible pathomechanisms in COVID-19 recovered individuals: a systematic review and meta-analysis
(2019) 178:686698.e14
Recommended maintenance doses are 5 mg, 10 mg, or 15 mg once weekly, and 15 mg is the maximum
However, over time and with sun exposure, we recommend occasional booster treatments to sustain your glow